#BEGIN_DRUGCARD DB03161

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C15H24N2O15P2

# Chemical_IUPAC_Name:
{[hydroxy({[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxy})phosphoryl]oxy}({[(2S,3R,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Thymidine-5'-Diphospho-Beta-D-Xylose

# HET_ID:
TDX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C15H24N2O15P2/c1-6-3-17(15(23)16-13(6)22)10-2-7(18)9(30-10)5-29-33(24,25)32-34(26,27)31-14-12(21)11(20)8(19)4-28-14/h3,7-12,14,18-21H,2,4-5H2,1H3,(H,24,25)(H,26,27)(H,16,22,23)/t7-,8+,9+,10-,11-,12+,14-/m1/s1

# InChI_Key:
InChIKey=AJUADKZRQSBUAK-BYMGEYMMSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3161

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
534.303

# Molecular_Weight_Mono:
534.065191132

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KEP

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
-1.7

# Predicted_Water_Solubility:
1.13e+01 g/l

# Primary_Accession_No:
DB03161

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936589

# PubChem_Substance_ID:
46505396

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03034

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=CN([C@H]2C[C@@H](O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)O[C@H]3OC[C@H](O)[C@@H](O)[C@@H]3O)O2)C(=O)NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:58 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D78182

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rmlB

# Drug_Target_1_Gene_Sequence:
>1047 bp
ATGACAGAATATAAAAACATTATCGTTACCGGTGGCGCTGGATTCATCGGTTCAAACTTT
GTCCACTACGTTTACAATAATCACCCAGATGTCCATGTGACTGTTCTTGACAAACTCACT
TACGCTGGTAACCATGCTAACCTTGAAGAAATTCTTGGCGACCGTGTAGAGTTGGTTGTT
GGGGACATCGCAGACAGCGAATTGGTAGATAAATTGGCTGCCAAAGCGGATGCTATTGTC
CACTATGCGGCTGAAAGCCACAATGACAATTCACTAAAAGATCCATCACCATTTATTTAC
ACTAACTTTGTTGGAACTTATACCTTGTTGGAAGCTGCACGCAAATACGACATCCGTTTC
CACCACGTCTCAACTGATGAAGTTTACGGTGATCTTCCGCTACGTGAAGATTTGCCGGGC
CACGGTGAAGGTCCGGGTGAAAAATTCACAGCTGAAACGAAATACAATCCATCATCGCCT
TATTCATCAACCAAGGCAGCCTCTGACTTGATTGTCAAGGCTTGGGTGCGATCTTTTGGT
GTGAAAGCAACCATTTCCAACTGTTCAAACAACTATGGACCTTACCAACACATCGAAAAA
TTCATTCCGCGCCAAATTACTAACATCCTGTCAGGTATCAAACCAAAACTCTATGGTGAA
GGTAAGAACGTGCGTGACTGGATTCACACCAATGACCATTCAACAGGAGTTTGGGCAATT
CTCACTAAAGGCCGCATCGGCGAAACTTATCTCATCGGTGCTGATGGTGAAAAGAACAAC
AAAGAAGTGCTCGAACTTATCCTTGAAAAAATGAGTCAGCCAAAAGACGCATACGACCAT
GTAACAGACCGTGCAGGTCATGATCTTCGTTATGCCATTGATTCGACAAAGCTGCGTGAG
GAACTTGGCTGGAAACCACAATTCACTAATTTTGAAGAAGGCTTGGAAGATACCATTAAA
TGGTATACTGAGCATGAAGATTGGTGGAAAGCTGAAAAGGAAGCAGTCGAAGCCAACTAT
GCCAAAACACAAAAAATACTTAATTAA

# Drug_Target_1_General_Function:
Involved in dTDP-glucose 4,6-dehydratase activity

# Drug_Target_1_General_References:
11796113	Allard ST, Beis K, Giraud MF, Hegeman AD, Gross JW, Wilmouth RC, Whitfield C, Graninger M, Messner P, Allen AG, Maskell DJ, Naismith JH: Toward a structural understanding of the dehydratase mechanism. Structure. 2002 Jan;10(1):81-92.
12397186	Ajdic D, McShan WM, McLaughlin RE, Savic G, Chang J, Carson MB, Primeaux C, Tian R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti JJ: Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14434-9. Epub 2002 Oct 23.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4499

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
39281

# Drug_Target_1_Name:
dTDP-glucose 4,6-dehydratase

# Drug_Target_1_Number_of_Residues:
348

# Drug_Target_1_PDB_ID:
1OC2

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_1_Protein_Sequence:
>dTDP-glucose 4,6-dehydratase
MTEYKNIIVTGGAGFIGSNFVHYVYNNHPDVHVTVLDKLTYAGNRANLEEILGDRVELVV
GDIADSELVDKLAAKADAIVHYAAESHNDNSLKDPSPFIYTNFVGTYILLEAARKYDIRF
HHVSTDEVYGDLPLREDLPGHGEGPGEKFTAETKYNPSSPYSSTKAASDLIVKAWVRSFG
VKATISNCSNNYGPYQHIEKFIPRQITNILSGIKPKLYGEGKNVRDWIHTNDHSTGVWAI
LTKGRIGETYLIGADGEKNNKEVLELILEKMSQPKNAYDHVTDRAGHDLRYAIDSTKLRE
ELGWKPQFTNFEEGLEDTIKWYTEHEDWWKAEKEAVEANYAKTQKILN

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
dTDP-glucose = dTDP-4-dehydro-6-deoxy-D- glucose + H(2)O

# Drug_Target_1_SwissProt_ID:
P95780

# Drug_Target_1_SwissProt_Name:
RMLB_STRMU

# Drug_Target_1_Synonyms:
EC 4.2.1.46

# Drug_Target_1_Theoretical_pI:
5.73

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AJ509828

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
rmlC

# Drug_Target_2_Gene_Sequence:
>594 bp
ATGACAGAAAACTTTTTCGGTAAAACACTAGCAGCTCGCCCAGTTGAAGCTATTCCAGGA
ATGTTAGAATTTGACATTCCTGTTCATGGCGACAACCGTGGCTGGTTTAAGGAGAACTTC
CAAAAGGAAAAAATGTTGCCTCTCGGCTTTCCTGAAAGCTTCTTTGCAGAAGGAAAATTG
CAGAATAATGTTTCCTTCTCTCGTAAAAACGTTCTTCGTGGTCTTCACGCAGAGCCTTGG
GATAAATACATTTCAGTAGCAGACGGCGGTAAGGTTTTGGGAACTTGGGTCGATCTACGT
GAAGGCGAAACCTTCGGTAATACCTACCAAACCGTTATCGATGCTTCAAAAAGTATCTTC
GTTCCGCGCGGAGTAGCCAATGGTTTCCAAGTCTTGTCAGATTTCGTGGCTTACAGCTAC
TTGGTTAACGACTACTGGGCTTTGGAACTCAAGCCTAAGTATGCTTTCGTCAACTACGCT
GACCCTAGCCTCGACATCAAGTGGGAAAACCTAGAAGAAGCAGAAGTTTCAGAAGCAGAT
GAAAACCACCCATTCCTCAAGGACGTCAAGCCTTTGAGAAAAGAGGACCTCTAA

# Drug_Target_2_General_Function:
Involved in dTDP-4-dehydrorhamnose 3,5-epimerase activity

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5127

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
22463

# Drug_Target_2_Name:
DTDP-4-dehydrorhamnose 3,5-epimerase

# Drug_Target_2_Number_of_Residues:
197

# Drug_Target_2_PDB_ID:
1NZC

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00908	dTDP_sugar_isom

# Drug_Target_2_Protein_Sequence:
>DTDP-4-dehydrorhamnose 3,5-epimerase
MTENFFGKTLAARPVEAIPGMLEFDIPVHGDNRGWFKENFQKEKMLPLGFPESFFAEGKL
QNNVSFSRKNVLRGLHAEPWDKYISVADGGKVLGTWVDLREGETFGNTYQTVIDASKSIF
VPRGVANGFQVLSDFVAYSYLVNDYWALELKPKYAFVNYADPSLDIKWENLEEAEVSEAD
ENHPFLKDVKPLRKEDL

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q8GIQ0

# Drug_Target_2_SwissProt_Name:
Q8GIQ0_STRSU

# Drug_Target_2_Synonyms:
EC 5.1.3.13

# Drug_Target_2_Theoretical_pI:
4.65

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03161
